Form 4 for IDXX Idexx Laboratories
Accepted 2023-02-16 00:00:00 ET · period of report 2023-02-14 · accession 0001567619-23-003220 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-02-16 | 2023-02-14 | IDXX | MCKEON BRIAN P | CFO, Executive VP | M - OptEx | $0.00 | +1,928 | 30.2K | +7% | $0 |
| D | 2023-02-16 | 2023-02-14 | IDXX | MCKEON BRIAN P | CFO, Executive VP | F - Tax | $503.65 | -1,208 | 29.0K | -4% | -$608.4K |
| DM | 2023-02-16 | 2023-02-14 | IDXX | MCKEON BRIAN P | CFO, Executive VP | M - OptEx | — | -1,928 | 4,199 | -31% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-14 | M | A | 433 | $0.00 | 29,682.64 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-14 | M | A | 504 | $0.00 | 28,814.64 | D | — | — | |
| 3 | Common | Common Stock | 2023-02-14 | M | A | 435 | $0.00 | 29,249.64 | D | — | — | |
| 4 | Common | Common Stock | 2023-02-14 | F | D | 1,208 | $503.65 | 29,030.64 | D | — | — | |
| 5 | Common | Common Stock | 2023-02-14 | M | A | 253 | $0.00 | 29,935.64 | D | — | — | |
| 6 | Common | Common Stock | 2023-02-14 | M | A | 303 | $0.00 | 30,238.64 | D | — | — | |
| 7 | Derivative | Restricted Stock Unit | 2023-02-14 | M | D | 303 | — | 3,896 | D | — · — to — | 303 Common Stock | (F6) Not applicable. (F5) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2023. |
| 8 | Derivative | Restricted Stock Unit | 2023-02-14 | M | D | 504 | — | 5,320 | D | — · — to — | 504 Common Stock | (F6) Not applicable. (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2019. |
| 9 | Derivative | Restricted Stock Unit | 2023-02-14 | M | D | 435 | — | 4,885 | D | — · — to — | 435 Common Stock | (F6) Not applicable. (F2) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020. |
| 10 | Derivative | Restricted Stock Unit | 2023-02-14 | M | D | 433 | — | 4,452 | D | — · — to — | 433 Common Stock | (F6) Not applicable. (F3) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021. |
| 11 | Derivative | Restricted Stock Unit | 2023-02-14 | M | D | 253 | — | 4,199 | D | — · — to — | 253 Common Stock | (F6) Not applicable. (F4) Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022. |